Jared Wickerham/Getty Images
Prior to the beginning of the season, Sandy Alderson brought aboard two talented yet injury-prone starters to help out the team's depleted pitching staff; Chris Young and Chris Capuano. The idea was that while neither was likely to remain healthy for a full season, it was well worth giving them incentive-laden contracts if they could match levels of production they've displayed in years past. As could have been expected, one of these pitchers (Chris Young) hit the DL early in the season for good with shoulder tightness. Capuano has been a different story entirely. To the tune of a solid 1.35 WHIP and 7.6 K/9 rate, he's provided the Mets with 102.2 very solid innings.
After reading the above, one might wonder why I'd implore the Mets to measure Capuano's value on the trading market. Simply put, if there's one group of baseball players that tend to receive absurdly disproportionate trade returns from general managers, it's starting pitchers. Playoff bound teams are always looking to shore up their rotations in anticipation of the season's final push, and Chris Capuano could figure to be a very attractive target.
The unfortunate fact of the matter regarding Capuano is that his injury history can't be ignored. A former recipient of Tommy John surgery, Capuano's health didn't allow him to pitch in a major league game from 2007-2010, and he's left a handful of games early this season due to various health concerns. It's a safe bet that Sandy Alderson will try to target trigger-happy GMs who are looking for reliable starters, even at the cost of turning a blind eye to legitimate injury concerns. The Mets have some young talented starters available at the Triple-A level (Chris Schwinden an Dylan Owen come to mind) who could fill in Capuano's vacant rotation spot. If the Mets could net a return of two or so B-level prospects or more, why not deal Capuano?